Back
INmune Bio, Inc. INMB · Insights
INmune Bio, Inc. is a clinical-stage biotechnology company focused on developing novel immunotherapi... Price1.13
Market Cap34.98 M
Float27.96 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro